Aldeyra Therapeutics (ALDX) Deferred Taxes (2019)

Aldeyra Therapeutics (ALDX) has reported Deferred Taxes for 1 consecutive years, with -$1.3 million the latest figure, recorded in Q1 2019.

• For the quarter ending Q1 2019, Deferred Taxes changed N/A year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2019 stood at -$1.3 million (changed N/A YoY), and the FY2020 full-year result was -$479265.0, up 63.41% from the prior year.
• Deferred Taxes steadied at -$1.3 million in Q1 2019 per ALDX's latest filing.
• Across five years, Deferred Taxes topped out at -$1.3 million in Q1 2019 and bottomed at -$1.3 million in Q1 2019.